Correlation Between Inhibrx and Curative Biosciences
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Curative Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Curative Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Curative Biosciences, you can compare the effects of market volatilities on Inhibrx and Curative Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Curative Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Curative Biosciences.
Diversification Opportunities for Inhibrx and Curative Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inhibrx and Curative is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Curative Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curative Biosciences and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Curative Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curative Biosciences has no effect on the direction of Inhibrx i.e., Inhibrx and Curative Biosciences go up and down completely randomly.
Pair Corralation between Inhibrx and Curative Biosciences
If you would invest 0.01 in Curative Biosciences on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Curative Biosciences or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Curative Biosciences
Performance |
| Timeline |
| Inhibrx |
| Curative Biosciences |
Inhibrx and Curative Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Curative Biosciences
The main advantage of trading using opposite Inhibrx and Curative Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Curative Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curative Biosciences will offset losses from the drop in Curative Biosciences' long position.| Inhibrx vs. Eliem Therapeutics | Inhibrx vs. Scpharmaceuticals | Inhibrx vs. Milestone Pharmaceuticals | Inhibrx vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |